The Independent reports crucial developments in various social issues, emphasizing the importance of accessible journalism. A significant story involves AstraZeneca's cancellation of a £450 million investment in a UK vaccine manufacturing plant, originally promised in the previous government's budget. Science minister Sir Chris Bryant expressed regret about the deal falling through due to changed investment terms that no longer met taxpayer interests. This situation highlights ongoing challenges in sustaining pharmaceutical investments in the UK amidst shifting political support and expectations regarding research and development contributions.
The decision reverses an announcement made by then-chancellor Jeremy Hunt at last year's March budget that would have seen the pharmaceutical company expand its existing facility in Speke.
Sir Chris Bryant stated the Government feels regretful about the plan being ditched and would prefer to have got this over the line.
The pharmaceutical company cancelled a 450 million investment in a vaccine manufacturing plant in Merseyside, saying Labour failed to match the previous government's offer of support.
Since the spring budget of 2024, AstraZeneca confirmed a significant change in the composition of their proposed investment, resulting in a smaller level of research and development being conducted in the UK.
Collection
[
|
...
]